What is PharmIntell?
PharmIntell operates as a critical intelligence partner for the pharmaceutical, medical device, and biotechnology industries. By providing high-fidelity literature searching, regulatory compliance support, and competitive intelligence, the company enables its clients to make data-backed scientific and business decisions. Their service model, which includes specialized library and information center management, positions them as an essential outsourcing partner for organizations seeking to maintain a competitive edge in a rapidly evolving global market. Through tailored insights, PharmIntell bridges the gap between raw data and actionable strategic intelligence.
How much funding has PharmIntell raised?
PharmIntell has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in PharmIntell
PPP
Public-Private Partnership
What's next for PharmIntell?
With this late-stage financing, PharmIntell is well-positioned to scale its operational infrastructure and expand its suite of analytical tools. The company is expected to leverage this capital to enhance its proprietary intelligence platforms, potentially integrating advanced machine learning to further streamline regulatory reporting and literature synthesis. As the life sciences industry faces increasing pressure for transparency and rapid innovation, PharmIntell's focus on high-quality information management will likely serve as a primary growth driver, allowing the firm to capture a larger share of the outsourcing market for specialized research and compliance services.
See full PharmIntell company page
